1. Fleckenstein A, Nakayama K, Fleckenstein-Grün G, Byon Y . Interactions of H ions, Ca-antagonistic drugs and cardiac glycosides with excitation-contraction coupling of vascular smooth muscle Ionic actions on vascular smooth muscle. Springer 1976, 117–123.
2. Vater W, Kroneberg G, Hoffmeister F, Saller H, Meng K, Oberdorf A, Puls W, Schlossmann K, Stoepel K . Pharmacology of 4-(2'-nitrophenyl)-2, 6-dimethyl-1, 4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040). Arzneimittel-Forschung 1972; 22: 1–14.
3. Fleckenstein A, Tritthart H, Döring H-J, Byron KY . BAY a 1040 — ein hochaktiver Ca++-antagonistischer Inhibitor der elektro-mechanischen Koppelungsprozesse im Warmblüter-Myocard. Arzneimittelforsch 1972; 22: 22–23.
4. Hashimoto K, Taira N, Sato S, Chiba S, Hashimoto K, Tamura K, Endoh M, Iijima T . Pharmacological action on nitrophenyi-dimethyl-dihydropyridine-deri-vatlve. Heart 1971; 3: 1294–1304.
5. Murakami M, Murakami E, Takekoshi N, Tsuchiya M, Kin T, Onoe T, Takeuchi N, Funatsu T, Hara S, Ishise S . Antihypertensive effect of 4 (-2'-nitrophenyl)-2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarbonic acid dimethylester (nifedipine, bay-a 1040), a new coronary dilator. Jpn Heart J 1972; 13: 128–135.